Treatment with an SLC12A1 antagonist inhibits tumorigenesis in a subset of hepatocellular carcinomas.
Teng F, Guo M, Liu F, Wang C, Dong J, Zhang L, Zou Y, Chen R, Sun K, Fu H, Fu Z, Guo W, Ding G.
Teng F, et al. Among authors: guo w, guo m.
Oncotarget. 2016 Aug 16;7(33):53571-53582. doi: 10.18632/oncotarget.10670.
Oncotarget. 2016.
PMID: 27447551
Free PMC article.